UF researcher receives grant for clinical trial for malignant pediatric gliomas
The grant will fund a phase I/II clinical trial for malignant pediatric gliomas using 8R-70CAR T cells.
All Posts by
The grant will fund a phase I/II clinical trial for malignant pediatric gliomas using 8R-70CAR T cells.
The study will focus on understanding the role of DAXX in triple negative breast cancer.
The study aims to define the impact of the proteomic and metabolomic landscape of leukemic cells on patient risk and therapeutic outcome.
The new research will focus on making a tumor model to test new immunotherapies.
The research will have ramifications for development of DNA repair capacity assays to assess cancer susceptibility or therapeutic efficacy.
Kiley Graim, Ph.D., and her team will study genomic information from a range of animals to gain insight into the mechanisms of rare human cancers.
Juan Guan, Ph.D., will explore the mechanisms behind the assembly and regulation of non-canonical biomolecular condensates.
The team will gather insight into Florida-specific trends and social determinants of cervical cancer.
The grants are part of a block award given to UF that enables the Cancer Center to support early-stage investigations.
The projects are designed to collect preliminary data required to test novel ideas with the goal of creating a foundation for larger studies.